HAN Advisory – Increased Respiratory Syncytial Virus (RSV) infections and recommended use of Palivizumab
CDPHE has released a health advisory on increased Respiratory Syncytial Virus (RSV) infections in Colorado, particularly among infants and children below the age of two. See the following for more information: